Medicated Feed Additives Market by Type (Antibiotics, Antioxidants, Coccidiostats), Form (Granule, Liquid, Powder), Animal Type, Application - Global Forecast 2025-2032
Description
The Medicated Feed Additives Market was valued at USD 10.58 billion in 2024 and is projected to grow to USD 11.58 billion in 2025, with a CAGR of 9.29%, reaching USD 21.54 billion by 2032.
An authoritative overview of how regulatory pressure, stewardship needs, and supply dynamics are redefining priorities and decision-making across the medicated feed additives value chain
The medicated feed additives sector stands at a strategic crossroads where animal health imperatives, regulatory evolution, and supply chain constraints intersect to reshape industry priorities. Stakeholders across ingredient suppliers, feed manufacturers, veterinarians, and livestock producers are confronting the need to balance therapeutic efficacy with stewardship, while optimizing feed formulations for performance and animal welfare. As a result, corporate strategy must now account for evolving use-case requirements alongside procurement reliability and compliance pathways.
This analysis frames the landscape through the lenses of product functionality, formulation trends, animal demographics, and application objectives. It emphasizes how technological innovation in additive delivery and analytical testing is enabling more targeted interventions and how collaboration across the value chain is becoming essential to manage risk. The introduction also underscores the practical implications of regulatory scrutiny and international trade dynamics, which together drive reassessment of sourcing, substitution strategies, and product development pipelines. By establishing this foundational context, readers gain a clear perspective on where competitive advantage can be created and which levers industry leaders should prioritize to navigate near-term disruption and longer-term transformation.
How regulatory restriction, formulation innovation, and supply chain resilience are converging to transform strategic priorities and competitive differentiation in medicated feed additives
The landscape for medicated feed additives is experiencing transformative shifts driven by three mutually reinforcing forces: heightened regulatory scrutiny around antibiotic use, the rise of targeted formulations and delivery systems, and a reorientation of supply chains toward resilience and compliance. Regulatory initiatives aimed at curbing routine antibiotic inclusion have prompted product reformulation efforts and a strategic pivot toward alternatives that preserve animal health while aligning with antimicrobial stewardship goals. At the same time, innovation in additive forms and analytical approaches is enabling more precise dosing and monitoring, thereby improving efficacy and reducing off-target exposures.
Concurrently, procurement teams and ingredient suppliers are re-evaluating sourcing strategies to manage geopolitical risk, tariff impacts, and raw material traceability. These pressures are accelerating investments in upstream traceability systems, supplier diversification, and strategic inventory buffers. As a consequence, companies that integrate regulatory foresight with agile formulation capabilities and transparent supply chains are gaining an operational advantage. Looking ahead, the sector will increasingly reward actors that translate regulatory compliance into product differentiation, operational continuity, and demonstrable stewardship performance, thereby aligning commercial success with public health objectives.
The operational and strategic repercussions of 2025 tariff adjustments on procurement, supplier diversification, and production localization across the medicated feed additives supply chain
United States tariff adjustments announced for 2025 are reshaping cost and sourcing considerations for global ingredient flows, prompting stakeholders to reassess procurement footprints and contractual terms. Tariff-related cost pressures are magnifying the importance of supplier diversification and nearshoring options, as organizations seek alternatives that reduce exposure to sudden duty changes while preserving quality and regulatory compliance. In response, some companies are accelerating qualification of secondary suppliers, reconfiguring logistics strategies, and renegotiating long-term agreements to stabilize input availability and cost predictability.
Beyond immediate procurement responses, tariff developments are influencing longer-term strategic choices, including vertical integration of critical processing steps and selective localization of high-value additive manufacturing. Firms with flexible formulation platforms and adaptable supply networks are positioned to reallocate production where economic and regulatory conditions are most favorable. Moreover, enhanced scenario planning and contract clauses that address tariff pass-through have become more commonplace in procurement playbooks, enabling firms to absorb shocks without disrupting feed production schedules. Altogether, these tariff dynamics are forcing a more disciplined approach to sourcing risk management and operational contingency planning across the sector.
Granular segmentation insights that map product classes, formulation formats, animal-specific needs, and application objectives to regulatory risk and commercial opportunity
Segmentation analysis reveals distinct performance and risk characteristics across product types, forms, animal targets, and applications that should inform portfolio and go-to-market strategy. Based on Type, product categories include Antibiotics, Antioxidants, Coccidiostats, Enzymes, Minerals, and Vitamins, with Antibiotics further disaggregated into Ionophores, Macrolides, and Tetracyclines; each class responds to different therapeutic and nutritional objectives, regulatory constraints, and customer acceptance dynamics. Based on Form, industry activity spans Granule, Liquid, and Powder presentations, with form choices influencing handling, mix uniformity, stability, and dosing precision in feed mills and on-farm applications. Based on Animal Type, product development and commercialization efforts are directed toward Aquaculture, Cattle, Poultry, and Swine populations, each of which has unique husbandry practices, susceptibility profiles, and economic drivers that affect additive selection and labeling requirements.
Based on Application, use cases are oriented around Disease Prevention, Growth Promotion, and Nutrient Supplementation, and these end-use categories shape regulatory pathways, claims permissible on labels, and the metrics buyers use to evaluate effectiveness. Integrating these segmentation lenses shows where technical differentiation matters most and where regulatory friction is highest. For instance, formulations intended for growth promotion face greater scrutiny in several regulatory jurisdictions, whereas nutrient supplementation and antioxidant applications often encounter fewer labeling constraints and may offer clearer routes to market. Consequently, product strategies that align type and form to animal-specific husbandry practices and permissible application claims will retain commercial relevance while minimizing regulatory friction.
A regional playbook that explains how differing regulatory regimes, supply chain structures, and husbandry practices across major geographies shape commercial and compliance pathways
Regional dynamics exert a strong influence on regulatory expectations, supply chain design, and product adoption patterns, requiring geographically nuanced strategies. In the Americas, regulatory trends and consumer expectations are driving shifts in antibiotic stewardship and increasing demand for transparent supply chains, while feed manufacturers prioritize operational continuity and integration with domestic agricultural systems. Europe, Middle East & Africa presents a heterogeneous landscape in which stringent EU regulations coexist with varied regulatory frameworks in other countries, leading to differentiated product acceptance and the need for region-specific compliance strategies. Asia-Pacific is characterized by a mix of rapid production scale-up, diverse husbandry practices, and evolving regulatory approaches that create both high demand and complex market access requirements.
These regional distinctions translate into practical implications for commercialization, from label claims and residue testing protocols to logistic networks and local manufacturing partnerships. Companies that tailor regulatory dossiers, quality assurance systems, and distribution models to regional priorities are more effective at achieving product adoption and long-term supplier relationships. Moreover, cross-regional learning-such as adapting stewardship protocols developed in one jurisdiction to meet emerging expectations in another-can accelerate compliance readiness and competitive positioning across multiple geographies.
Why technical expertise, regulatory navigation capability, and supply reliability are the primary competitive differentiators shaping firm strategies and partnerships in the sector
Competitive dynamics in medicated feed additives are increasingly defined by technical expertise, regulatory intelligence, and the ability to deliver consistent supply under evolving trade conditions. Leading firms are investing in R&D capabilities to optimize formulations for stability, palatability, and dosing accuracy, and are building regulatory affairs teams capable of navigating diverse approval pathways. At the same time, strategic partnerships between ingredient manufacturers, feed mills, and veterinary services are becoming more common, as integrated solutions offer end users clearer performance benefits and simplified compliance.
Operational excellence is another differentiator: producers that demonstrate robust quality management systems, traceability, and rapid responsiveness to residue or compliance inquiries gain preferential access to large buyers and integrated supply chains. Additionally, some companies are pursuing modular manufacturing and regional production hubs to limit exposure to trade disruptions and to meet localized regulatory or labeling requirements. Overall, competitive positioning increasingly depends on the combination of technical credibility, regulatory foresight, and supply reliability rather than on commodity pricing alone.
Actionable strategic priorities that balance regulatory foresight, formulation flexibility, supplier diversification, and evidence-driven commercial engagement to build durable advantage
Industry participants should pursue a pragmatic roadmap that balances regulatory compliance, innovation, and supply resilience to secure sustainable advantage. First, embed regulatory intelligence into product development cycles so that formulation decisions and label claims are informed by foreseeable policy trajectories and residue testing expectations. Second, invest in formulation flexibility and delivery technologies that enable rapid substitution among forms-granule, liquid, and powder-reducing production friction and increasing options for end users. Third, strengthen supplier qualification processes and diversify sourcing to reduce tariff and geopolitical exposure while maintaining quality and traceability standards.
In parallel, develop targeted value propositions aligned to animal-specific needs and application objectives, such as disease prevention protocols for poultry or nutrient supplementation regimens for aquaculture, to enhance commercial relevance. Collaborate with veterinary networks and feed integrators to validate product performance under real-world conditions and to build evidence-based narratives that support responsible use. Finally, incorporate scenario-based procurement clauses and contingency plans to manage cost volatility and to ensure continuity of supply, thereby protecting feed production and customer relationships during periods of market disruption.
A transparent methodology integrating practitioner interviews, regulatory documentation, and technical literature with cross-validation to ensure reproducible and actionable insights
This research synthesizes primary interviews, technical literature, and regulatory documentation to produce a disciplined and transparent assessment of industry dynamics. Primary inputs included structured interviews with industry practitioners across ingredient manufacturing, feed formulation, veterinary services, and distribution, supplemented by expert consultations with regulatory affairs specialists. Secondary sources encompassed peer-reviewed journals, standards and guideline documents from regulatory authorities, and technical white papers describing formulation science and additive stability considerations.
Analytical methods combined qualitative thematic analysis with comparative assessment of regional regulatory frameworks and supply chain configurations. Cross-validation techniques were applied to reconcile interview insights with documented regulatory shifts and published technical findings, ensuring consistency and plausibility. Limitations of the approach and areas for further primary research are identified so that readers can prioritize follow-on studies where greater granularity or company-level data is required. The methodology emphasizes reproducibility and traceability, enabling stakeholders to understand the evidence base behind the conclusions and to adapt the approach for their own internal analyses.
Concluding perspective on how integrated regulatory foresight, formulation adaptability, and resilient sourcing convert disruption into strategic advantage across the sector
In summary, the medicated feed additives sector is undergoing a structural recalibration driven by regulatory stewardship imperatives, formulation and delivery innovation, and supply chain realignment in response to trade shifts. These forces are reshaping where and how companies invest in R&D, how they structure supplier networks, and how they position products relative to animal health and welfare objectives. Firms that proactively integrate regulatory foresight into product design, build flexible formulation and manufacturing capabilities, and establish robust sourcing strategies will be better placed to convert change into competitive advantage.
Decision-makers should treat stewardship and compliance not simply as constraints but as opportunities to differentiate through demonstrable performance and transparency. By aligning technical development, commercial narratives, and supply chain resilience, organizations can meet stakeholder expectations and secure long-term customer relationships. The conclusion underscores the importance of an integrated approach that leverages scientific credibility, operational rigor, and strategic foresight to navigate the period of transition effectively.
Please Note: PDF & Excel + Online Access - 1 Year
An authoritative overview of how regulatory pressure, stewardship needs, and supply dynamics are redefining priorities and decision-making across the medicated feed additives value chain
The medicated feed additives sector stands at a strategic crossroads where animal health imperatives, regulatory evolution, and supply chain constraints intersect to reshape industry priorities. Stakeholders across ingredient suppliers, feed manufacturers, veterinarians, and livestock producers are confronting the need to balance therapeutic efficacy with stewardship, while optimizing feed formulations for performance and animal welfare. As a result, corporate strategy must now account for evolving use-case requirements alongside procurement reliability and compliance pathways.
This analysis frames the landscape through the lenses of product functionality, formulation trends, animal demographics, and application objectives. It emphasizes how technological innovation in additive delivery and analytical testing is enabling more targeted interventions and how collaboration across the value chain is becoming essential to manage risk. The introduction also underscores the practical implications of regulatory scrutiny and international trade dynamics, which together drive reassessment of sourcing, substitution strategies, and product development pipelines. By establishing this foundational context, readers gain a clear perspective on where competitive advantage can be created and which levers industry leaders should prioritize to navigate near-term disruption and longer-term transformation.
How regulatory restriction, formulation innovation, and supply chain resilience are converging to transform strategic priorities and competitive differentiation in medicated feed additives
The landscape for medicated feed additives is experiencing transformative shifts driven by three mutually reinforcing forces: heightened regulatory scrutiny around antibiotic use, the rise of targeted formulations and delivery systems, and a reorientation of supply chains toward resilience and compliance. Regulatory initiatives aimed at curbing routine antibiotic inclusion have prompted product reformulation efforts and a strategic pivot toward alternatives that preserve animal health while aligning with antimicrobial stewardship goals. At the same time, innovation in additive forms and analytical approaches is enabling more precise dosing and monitoring, thereby improving efficacy and reducing off-target exposures.
Concurrently, procurement teams and ingredient suppliers are re-evaluating sourcing strategies to manage geopolitical risk, tariff impacts, and raw material traceability. These pressures are accelerating investments in upstream traceability systems, supplier diversification, and strategic inventory buffers. As a consequence, companies that integrate regulatory foresight with agile formulation capabilities and transparent supply chains are gaining an operational advantage. Looking ahead, the sector will increasingly reward actors that translate regulatory compliance into product differentiation, operational continuity, and demonstrable stewardship performance, thereby aligning commercial success with public health objectives.
The operational and strategic repercussions of 2025 tariff adjustments on procurement, supplier diversification, and production localization across the medicated feed additives supply chain
United States tariff adjustments announced for 2025 are reshaping cost and sourcing considerations for global ingredient flows, prompting stakeholders to reassess procurement footprints and contractual terms. Tariff-related cost pressures are magnifying the importance of supplier diversification and nearshoring options, as organizations seek alternatives that reduce exposure to sudden duty changes while preserving quality and regulatory compliance. In response, some companies are accelerating qualification of secondary suppliers, reconfiguring logistics strategies, and renegotiating long-term agreements to stabilize input availability and cost predictability.
Beyond immediate procurement responses, tariff developments are influencing longer-term strategic choices, including vertical integration of critical processing steps and selective localization of high-value additive manufacturing. Firms with flexible formulation platforms and adaptable supply networks are positioned to reallocate production where economic and regulatory conditions are most favorable. Moreover, enhanced scenario planning and contract clauses that address tariff pass-through have become more commonplace in procurement playbooks, enabling firms to absorb shocks without disrupting feed production schedules. Altogether, these tariff dynamics are forcing a more disciplined approach to sourcing risk management and operational contingency planning across the sector.
Granular segmentation insights that map product classes, formulation formats, animal-specific needs, and application objectives to regulatory risk and commercial opportunity
Segmentation analysis reveals distinct performance and risk characteristics across product types, forms, animal targets, and applications that should inform portfolio and go-to-market strategy. Based on Type, product categories include Antibiotics, Antioxidants, Coccidiostats, Enzymes, Minerals, and Vitamins, with Antibiotics further disaggregated into Ionophores, Macrolides, and Tetracyclines; each class responds to different therapeutic and nutritional objectives, regulatory constraints, and customer acceptance dynamics. Based on Form, industry activity spans Granule, Liquid, and Powder presentations, with form choices influencing handling, mix uniformity, stability, and dosing precision in feed mills and on-farm applications. Based on Animal Type, product development and commercialization efforts are directed toward Aquaculture, Cattle, Poultry, and Swine populations, each of which has unique husbandry practices, susceptibility profiles, and economic drivers that affect additive selection and labeling requirements.
Based on Application, use cases are oriented around Disease Prevention, Growth Promotion, and Nutrient Supplementation, and these end-use categories shape regulatory pathways, claims permissible on labels, and the metrics buyers use to evaluate effectiveness. Integrating these segmentation lenses shows where technical differentiation matters most and where regulatory friction is highest. For instance, formulations intended for growth promotion face greater scrutiny in several regulatory jurisdictions, whereas nutrient supplementation and antioxidant applications often encounter fewer labeling constraints and may offer clearer routes to market. Consequently, product strategies that align type and form to animal-specific husbandry practices and permissible application claims will retain commercial relevance while minimizing regulatory friction.
A regional playbook that explains how differing regulatory regimes, supply chain structures, and husbandry practices across major geographies shape commercial and compliance pathways
Regional dynamics exert a strong influence on regulatory expectations, supply chain design, and product adoption patterns, requiring geographically nuanced strategies. In the Americas, regulatory trends and consumer expectations are driving shifts in antibiotic stewardship and increasing demand for transparent supply chains, while feed manufacturers prioritize operational continuity and integration with domestic agricultural systems. Europe, Middle East & Africa presents a heterogeneous landscape in which stringent EU regulations coexist with varied regulatory frameworks in other countries, leading to differentiated product acceptance and the need for region-specific compliance strategies. Asia-Pacific is characterized by a mix of rapid production scale-up, diverse husbandry practices, and evolving regulatory approaches that create both high demand and complex market access requirements.
These regional distinctions translate into practical implications for commercialization, from label claims and residue testing protocols to logistic networks and local manufacturing partnerships. Companies that tailor regulatory dossiers, quality assurance systems, and distribution models to regional priorities are more effective at achieving product adoption and long-term supplier relationships. Moreover, cross-regional learning-such as adapting stewardship protocols developed in one jurisdiction to meet emerging expectations in another-can accelerate compliance readiness and competitive positioning across multiple geographies.
Why technical expertise, regulatory navigation capability, and supply reliability are the primary competitive differentiators shaping firm strategies and partnerships in the sector
Competitive dynamics in medicated feed additives are increasingly defined by technical expertise, regulatory intelligence, and the ability to deliver consistent supply under evolving trade conditions. Leading firms are investing in R&D capabilities to optimize formulations for stability, palatability, and dosing accuracy, and are building regulatory affairs teams capable of navigating diverse approval pathways. At the same time, strategic partnerships between ingredient manufacturers, feed mills, and veterinary services are becoming more common, as integrated solutions offer end users clearer performance benefits and simplified compliance.
Operational excellence is another differentiator: producers that demonstrate robust quality management systems, traceability, and rapid responsiveness to residue or compliance inquiries gain preferential access to large buyers and integrated supply chains. Additionally, some companies are pursuing modular manufacturing and regional production hubs to limit exposure to trade disruptions and to meet localized regulatory or labeling requirements. Overall, competitive positioning increasingly depends on the combination of technical credibility, regulatory foresight, and supply reliability rather than on commodity pricing alone.
Actionable strategic priorities that balance regulatory foresight, formulation flexibility, supplier diversification, and evidence-driven commercial engagement to build durable advantage
Industry participants should pursue a pragmatic roadmap that balances regulatory compliance, innovation, and supply resilience to secure sustainable advantage. First, embed regulatory intelligence into product development cycles so that formulation decisions and label claims are informed by foreseeable policy trajectories and residue testing expectations. Second, invest in formulation flexibility and delivery technologies that enable rapid substitution among forms-granule, liquid, and powder-reducing production friction and increasing options for end users. Third, strengthen supplier qualification processes and diversify sourcing to reduce tariff and geopolitical exposure while maintaining quality and traceability standards.
In parallel, develop targeted value propositions aligned to animal-specific needs and application objectives, such as disease prevention protocols for poultry or nutrient supplementation regimens for aquaculture, to enhance commercial relevance. Collaborate with veterinary networks and feed integrators to validate product performance under real-world conditions and to build evidence-based narratives that support responsible use. Finally, incorporate scenario-based procurement clauses and contingency plans to manage cost volatility and to ensure continuity of supply, thereby protecting feed production and customer relationships during periods of market disruption.
A transparent methodology integrating practitioner interviews, regulatory documentation, and technical literature with cross-validation to ensure reproducible and actionable insights
This research synthesizes primary interviews, technical literature, and regulatory documentation to produce a disciplined and transparent assessment of industry dynamics. Primary inputs included structured interviews with industry practitioners across ingredient manufacturing, feed formulation, veterinary services, and distribution, supplemented by expert consultations with regulatory affairs specialists. Secondary sources encompassed peer-reviewed journals, standards and guideline documents from regulatory authorities, and technical white papers describing formulation science and additive stability considerations.
Analytical methods combined qualitative thematic analysis with comparative assessment of regional regulatory frameworks and supply chain configurations. Cross-validation techniques were applied to reconcile interview insights with documented regulatory shifts and published technical findings, ensuring consistency and plausibility. Limitations of the approach and areas for further primary research are identified so that readers can prioritize follow-on studies where greater granularity or company-level data is required. The methodology emphasizes reproducibility and traceability, enabling stakeholders to understand the evidence base behind the conclusions and to adapt the approach for their own internal analyses.
Concluding perspective on how integrated regulatory foresight, formulation adaptability, and resilient sourcing convert disruption into strategic advantage across the sector
In summary, the medicated feed additives sector is undergoing a structural recalibration driven by regulatory stewardship imperatives, formulation and delivery innovation, and supply chain realignment in response to trade shifts. These forces are reshaping where and how companies invest in R&D, how they structure supplier networks, and how they position products relative to animal health and welfare objectives. Firms that proactively integrate regulatory foresight into product design, build flexible formulation and manufacturing capabilities, and establish robust sourcing strategies will be better placed to convert change into competitive advantage.
Decision-makers should treat stewardship and compliance not simply as constraints but as opportunities to differentiate through demonstrable performance and transparency. By aligning technical development, commercial narratives, and supply chain resilience, organizations can meet stakeholder expectations and secure long-term customer relationships. The conclusion underscores the importance of an integrated approach that leverages scientific credibility, operational rigor, and strategic foresight to navigate the period of transition effectively.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
194 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Rising adoption of ionophore antibiotics to enhance poultry growth performance under antibiotic restrictions
- 5.2. Integration of phytogenic feed additives to mitigate antimicrobial resistance and improve gut health
- 5.3. Development of targeted probiotic formulations for swine to reduce post-weaning diarrhea incidence
- 5.4. Increased regulatory scrutiny driving shift towards non-antibiotic coccidiostats in poultry feed
- 5.5. Advances in encapsulation technologies for controlled release of veterinary drugs in livestock feed
- 5.6. Growth of precision nutrition platforms utilizing biomarkers to optimize medicated feed dosing
- 5.7. Expansion of medicated feed additive combinations addressing respiratory infections in dairy cattle
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Medicated Feed Additives Market, by Type
- 8.1. Antibiotics
- 8.1.1. Ionophores
- 8.1.2. Macrolides
- 8.1.3. Tetracyclines
- 8.2. Antioxidants
- 8.3. Coccidiostats
- 8.4. Enzymes
- 8.5. Minerals
- 8.6. Vitamins
- 9. Medicated Feed Additives Market, by Form
- 9.1. Granule
- 9.2. Liquid
- 9.3. Powder
- 10. Medicated Feed Additives Market, by Animal Type
- 10.1. Aquaculture
- 10.2. Cattle
- 10.3. Poultry
- 10.4. Swine
- 11. Medicated Feed Additives Market, by Application
- 11.1. Disease Prevention
- 11.2. Growth Promotion
- 11.3. Nutrient Supplementation
- 12. Medicated Feed Additives Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Medicated Feed Additives Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Medicated Feed Additives Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Adisseo
- 15.3.2. Ajinomoto Co. Inc.
- 15.3.3. Alltech, Inc.
- 15.3.4. Archer Daniels Midland Company
- 15.3.5. BASF SE
- 15.3.6. Boehringer Ingelheim Animal Health GmbH
- 15.3.7. Cargill, Incorporated
- 15.3.8. Ceva Santé Animale S.A.
- 15.3.9. Chr. Hansen Holding A/S
- 15.3.10. Elanco Animal Health Incorporated
- 15.3.11. Evonik Industries AG
- 15.3.12. Huvepharma EOOD
- 15.3.13. International Flavors & Fragrances Inc.
- 15.3.14. Jubilant Ingrevia Limited
- 15.3.15. Kemin Industries, Inc.
- 15.3.16. Koninklijke DSM N.V.
- 15.3.17. Land O'Lakes, Inc.
- 15.3.18. Merck & Co., Inc.
- 15.3.19. Novonesis Group
- 15.3.20. Novus International, Inc.
- 15.3.21. Nutreco N.V.
- 15.3.22. Phibro Animal Health Corporation
- 15.3.23. Virbac SA
- 15.3.24. Zagro Group
- 15.3.25. Zoetis Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
